NASDAQ: AMIXAutonomix Medical Inc Stock
$3.36+0.03 (+0.9%)
Updated Apr 26, 2024
AMIX Price
$3.36
Fair Value Price
N/A
Market Cap
$63.15M
52 Week Low
$2.50
52 Week High
$7.60
P/E
N/A
P/B
-11.29x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.32
Operating Cash Flow
N/A
Beta
0.2
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
AMIX Overview
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AMIX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AMIX's short-term assets ($1.69M) exceed its short-term liabilities ($973.00k)
Short-term Liabilities Financials
AMIX's long-term liabilities ($6.43M) exceed its short-term assets ($1.69M)
Long-term Liabilities Financials
AMIX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
There are 30 more AMIX due diligence checks available for Premium users.
Be the first to know about important AMIX news, forecast changes, insider trades & much more!
AMIX News
Valuation
AMIX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-11.29x
Industry
3.7x
AMIX's financial health
Profit margin
Revenue
$0.0
Net Income
-$3.1M
Profit Margin
0%
Assets to liabilities
Assets
$1.8M
Liabilities
$7.4M
Debt to equity
-1.32
AMIX's short-term assets ($1.69M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AMIX's long-term liabilities ($6.43M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AMIX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AMIX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$2.6M
Investing
$0.0
Financing
$1.6M
AMIX vs Medical Device Stocks
Autonomix Medical Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.